The NEET SS 2024 Diploma in Tuberculosis and Chest Disease Question Paper 2 was conducted as part of the national-level super speciality examination for admissions into DM and MCh programmes. This paper evaluates a candidate’s advanced understanding of pulmonary medicine, tuberculosis management, respiratory infections, critical care, imaging interpretation, interventional pulmonology, and evidence-based clinical decision-making. Candidates were required to attempt 100 questions in 150 minutes, with a total of 400 marks. Each correct answer awards 4 marks, while 1 mark is deducted for every incorrect response as per the NEET SS negative marking scheme.
NEET SS 2024 Diploma Tuberculosis and Chest Disease Question Paper 2 with Answer Key PDF
| NEET SS 2024 Diploma Tuberculosis and Chest Disease Question Paper with Solutions PDF | Download PDF | Check Solutions |

NEET SS 2024 Diploma Tuberculosis and Chest Disease Question Paper 2 with Solutions
a) Pulmonary Langerhans cell histiocytosis (PLCH). [5]
b) Lymphangioleiomyomatosis (LAM). [5]
a) Diagnosis and treatment of pneumocystis pneumonia. [5]
b) Treatment of pulmonary non-tuberculous mycobacterial (NTM) disease. [5]
a) Management of empyema. [5]
b) Management of tuberculosis in patient with renal disease. [5]
a) Diagnosis of the bronchiectasis. [5]
b) Management for inoperable patients of mycetoma lung. [5]
a) Radiological features of lung hydatid disease. [5]
b) Management for severe exacerbations of COPD. [5]
a) Tropical pulmonary eosinophilia. [5]
b) Treatment of pulmonary cystic echinococcosis. [5]
a) Molecular targeted therapy in advanced non-small-cell lung cancer. [5]
b) Treatment of sarcoidosis in patients who progress on or cannot use methotrexate. [5]
a) Sleep disorders related to abnormalities in REM sleep. [5]
b) Positive airway pressure (PAP) therapy for adults with obstructive sleep apnea (OSA). [5]
a) Surgical emphysema. [5]
b) Lung carcinoid tumors. [5]
a) Nicotine replacement therapies. [5]
b) Treatment of sarcoidosis in patients who progress on or cannot use methotrexate. [5]







Comments